Categories: All postsCannabis

Planet 13 gets a target raise from Beacon Securities

Planet 13 Holdings (Planet 13 Holdings CSE:PLTH) plans to acquire a dispensary licence in California is getting the thumbs up from Beacon Securities analyst Doug Cooper, who is raising his target price, calling the new event an excellent strategic initiative for the Nevada-based cannabis company to expand its Superstore brand.

US cannabis play Planet 13 recently announced a letter of intent to acquire a cannabis license for a dispensary in Santa Ana, California, for $10 million including $6 million in cash and 2.04 million shares valued at $4 million. (All figures in US dollars unless noted otherwise.)

In a June 10 client update, Cooper outlines the reasons why he likes the deal. First, there’s the synergies between P13’s Las Vegas operation and the Southern California market; second, there’s the fact that California and Los Angeles itself represent the largest cannabis market in the world (and is under-represented at present, says Cooper); third, Santa Ana is in Orange County, which has a population of 3.2 million and is a destination location; and fourth, at 40,000 sq. ft., the size of the proposed facility in Santa Ana would allow for a repeat of the Superstore’s ongoing success.

“Aside from its ideal location, the size of the facility is such that P13 can replicate the user experience defined by its Las Vegas Superstore, which has a plus-12-per-cent market share in Clark County after such six months,” says Cooper.

“While it is too early to revise our FY20 estimates or initiate FY21, we do believe the shares should start to reflect its move into the largest cannabis market in the world,” he says.

For Planet 13, Cooper is calling for fiscal 2019 revenue and adjusted EBITDA of $82.1 million and $20.5 million. He is maintaining his “Buy” rating with the new target of C$8.50 (was C$7.25), which represented a projected return of 194 per cent at the time of publication.

More Cantech Cannabis

We Hate Paywalls Too!

At Cantech Letter we prize independent journalism like you do. And we don't care for paywalls and popups and all that noise That's why we need your support. If you value getting your daily information from the experts, won't you help us? No donation is too small.

Make a one-time or recurring donation

Tagged with: plth
Jayson MacLean

Jayson is a writer, researcher and educator with a PhD in political philosophy from the University of Ottawa. His interests range from bioethics and innovations in the health sciences to governance, social justice and the history of ideas.

Recent Posts

It’s time to buy cannabis stocks, this analyst says

A major development came down the pipe this week at the U.S. Drug Enforcement Agency has reportedly decided to reschedule… [Read More]

7 hours ago

Is Generac stock a buy?

Following the company's first quarter results, Roth MKM analyst Chip Moore remains neutral on Generac Holdings (Generac Holdings Stock Quote,… [Read More]

18 hours ago

Bombardier is a buy, Desjardins says (May, 2024)

The stock has climbed slowly but surely since last October. But is there still money to be made on Bombardier?… [Read More]

20 hours ago

Should you buy AMZN? (May, 2024)

Following the company's first quarter results, Roth MKM analyst Rohit Kulkarni has maintained his "Buy" rating on Amazon (Amazon Stock… [Read More]

1 day ago

These cannabis stocks will benefit most from reclassification

It happened. The move that everyone in the cannabis sector was hoping for came about swiftly on the last day… [Read More]

2 days ago

Is AMD stock a buy? (May, 2024)

Following the company's first quarter results, Roth MKM analyst Suji Desilva has maintained his "Buy" rating on Advanced Micro Devices… [Read More]

2 days ago